当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 资产负债表

博瑞医药

(688166)

  

流通市值:225.77亿  总市值:225.77亿
流通股本:4.23亿   总股本:4.23亿

资产负债表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
流动资产:
  货币资金961,064,394.02606,217,317.45739,834,101.15812,681,675.88
  应收票据及应收账款316,637,331.11328,608,558.32266,222,283.98279,710,403.85
  其中:应收票据200,000-561,863.512,934,536.96
        应收账款316,437,331.11328,608,558.32265,660,420.47276,775,866.89
  应收款项融资13,377,809.95,495,627.6610,582,211.465,523,820.19
  预付款项62,200,221.4883,595,346.5689,901,721.5849,610,071.01
  其他应收款合计9,126,583.595,193,034.57,673,356.772,025,851.04
  存货364,252,795.45369,390,282.32372,419,753.39365,680,037.04
  其他流动资产61,843,039.3568,097,539.7257,294,239.6456,364,726.7
  流动资产合计1,788,502,174.91,466,597,706.531,543,927,667.971,571,596,585.71
非流动资产:
  长期应收款7,100,0004,100,0004,100,0004,100,000
  长期股权投资122,790,639.35133,689,407138,570,966.8937,969,215.94
  其他权益工具投资113,170,901.4793,763,126.4273,763,126.4286,144,167.78
  其他非流动金融资产133,413,698.5593,666,850.0476,207,977.9575,519,569.93
  投资性房地产56,683,844.5357,404,467.2158,125,089.8958,845,712.57
  固定资产1,548,113,4161,486,735,505.631,463,076,322.571,491,235,661.86
  在建工程1,187,202,917.021,237,886,571.451,235,714,599.621,201,042,721.66
  使用权资产17,026,652.4213,643,58617,251,757.5820,859,929.19
  无形资产79,529,289.3686,496,659.9386,792,258.7788,288,104.11
  开发支出302,773,742.35268,149,745.42224,490,016.39183,674,072.4
  商誉-3,120,1003,120,1003,120,100
  长期待摊费用36,412,050.4638,422,268.6939,872,684.9642,545,333.66
  递延所得税资产94,679,078.7180,785,460.4870,466,777.482,358,685.61
  其他非流动资产337,443,273.39295,608,586.5348,315,232.11337,973,436.39
  非流动资产合计4,036,339,503.613,893,472,334.773,839,866,910.553,713,676,711.1
  资产总计5,824,841,678.515,360,070,041.35,383,794,578.525,285,273,296.81
流动负债:
  短期借款110,108,222.21149,265,996.95168,732,665.76131,419,652.77
  交易性金融负债7,070,265193,138.98121,142.811,678,957.59
  应付票据及应付账款185,894,997.14188,968,432.68202,694,593.27209,466,569.37
  其中:应付票据19,500,00040,000,00050,000,00025,000,000
        应付账款166,394,997.14148,968,432.68152,694,593.27184,466,569.37
  合同负债25,559,585.4845,199,400.9928,821,616.1634,884,385.09
  应付职工薪酬56,171,009.5619,693,265.5218,236,63643,140,065.45
  应交税费22,225,392.198,204,424.745,783,760.558,575,171.41
  其他应付款合计8,689,748.6210,164,42452,899,975.249,914,134.51
  一年内到期的非流动负债845,206,281.51725,461,980.25661,156,902.04480,935,520.71
  其他流动负债19,380,694.5719,899,756.8518,555,160.6218,179,806.69
  流动负债合计1,280,306,196.281,167,050,820.961,157,002,452.45938,194,263.59
非流动负债:
  长期借款730,488,592.621,008,650,834.391,039,837,474.21,155,361,436.71
  应付债券657,977,546.33450,128,932.89454,709,579.64457,913,213.27
  租赁负债10,207,868.477,299,521.137,920,825.568,444,328.28
  长期应付款142,108,311.17126,019,137.3367,000,051.6336,231,046
  递延收益67,247,469.9269,202,364.9471,157,259.9673,112,154.99
  其他非流动负债90,330,188.63---
  非流动负债合计1,698,359,977.141,661,300,790.681,640,625,190.991,731,062,179.25
  负债合计2,978,666,173.422,828,351,611.642,797,627,643.442,669,256,442.84
所有者权益(或股东权益):
  实收资本(或股本)423,103,851423,102,473422,768,244422,466,646
  其他权益工具61,227,647.7961,234,285.4562,840,182.6375,639,147.66
  永续债---75,639,147.66
  资本公积1,076,097,485.441,036,377,197.611,094,526,817.771,076,444,676.59
  减:库存股20,051,308.6110,009,948.6410,009,948.6410,009,948.64
  其他综合收益-85,438,838.11-124,695,066.81-124,695,066.81-122,185,574.81
  盈余公积98,567,037.0386,060,862.5986,060,862.5985,464,856.69
  未分配利润967,660,900.48975,972,411.34942,825,589.68973,798,977.73
  归属于母公司股东权益合计2,521,166,775.022,448,042,214.542,474,316,681.222,501,618,781.22
  少数股东权益325,008,730.0783,676,215.12111,850,253.86114,398,072.75
  股东权益合计2,846,175,505.092,531,718,429.662,586,166,935.082,616,016,853.97
  负债和股东权益合计5,824,841,678.515,360,070,041.35,383,794,578.525,285,273,296.81
公告日期2026-03-202025-10-312025-08-292025-04-18
审计意见(境内)标准无保留意见
TOP↑